CClinicalTrials.gg
CompletedNCT03760302Updated Sep 8, 2021

Analgesia in ÖAMTC Helicopter Emergency Service in Austria

An observational study in Field Physician Care, Analgesics and Hypnotics, sponsored by Medical University Innsbruck. Completed at 1 site in Austria. Per ClinicalTrials.gov, last updated 2021-09-08.

Sponsored by Medical University Innsbruck · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
35,000
Sex
All
01

Study summary

A sufficient analgesia in injured or sick people is the main goal of physicians treating a patient. In emergency medicine potent analgesia like ketamine or opioids are routinely used. It is unknown if there are any severe side effects or if the use is safe while in use in a Helicopter Emergency Service equipped with emergency physicians.

02

Conditions studied

  • Field Physician Care
  • Analgesics
  • Hypnotics
  • Emergencies
  • Safety
  • Accident
  • Trauma, Multiple
  • Pain, Acute
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 35,000 is above the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Medical University Innsbruck is the lead sponsor of 182 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

All patients screened with the described inclusion criteria - eligible to be included in analysis.

Inclusion criteria

  • Analgesia or use of hypnotics in ÖAMTC Air Ambulance Service in Austria 2000-2016

Exclusion criteria

Exclusion Criteria:

  • No analgesia, or analgesia use not in connection to ÖAMTC Air Ambulance Service. Analgesia given not in the period of examination (2000-2016)
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
35,000 participants (actual)
Patient registry
No

Groups and cohorts

  • Patient given analgesics or hypnotics

    All patients treated with any kind of analgesics or hypnotics are analyzed and compared.

    Other: analgesics · Other: hypnotics

Interventions

  • Otheranalgesics

    analgesics given to a patient treated from HEMS

  • Otherhypnotics

    hypnotics given to a patient treated from HEMS

06

What researchers measure

Primary outcomes

  1. Successful analgesia

    Change in reported pain severity before and after treatment with analgesic. (Numeric Rating Scale, NRS, eleven-point scale reporting no pain=0, to maximum pain=10; 1-3 mild pain, 4-6 moderate pain, 7-10 severe pain)

    Time frame: 2000-2016

  2. Analgesic, drug type

    Use of analgesic (n= type of analgesic)

    Time frame: 2000-2016

  3. Analgesic, frequency

    Use of analgesic (n= frequency how often analgesic is used)

    Time frame: 2000-2016

  4. Analgesic, amount of analgesics

    Use of analgesic (n= amount of analgesic used in mg or µg)

    Time frame: 2000-2016

Secondary outcomes

  1. Side effects

    Type of side effect (respiratory arrest after use, hypoxemia, desaturation (SpO2\<90%), dead)

    Time frame: 2000-2016

  2. Frequency of side effects

    Frequency of side effects (frequency of side effect/n=total number of analgesic use; very common\>=1/10, common\>=1/100 and\<1/10, uncommon \>=1/1000 and \<1/100, rare \>=1/10000 and \<1/1000, very rare \<1/10000)

    Time frame: 2000-2016

  3. Severity of side effect

    severity of side effect (0=none, 1=mild, 2=moderate, 3=severe, 4=potentially life threatening)

    Time frame: 2000-2016

07

Study locations

1 site
  • General and Surgical Critical Care Medicine, Medical University of Innsbruck
    Innsbruck, 6020, Austria
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03760302
Lead sponsor
Medical University Innsbruck
Responsible party
Sponsor
First posted
Nov 30, 2018
Start date
Dec 1, 2018
Primary completion
Oct 26, 2019
Completion
Feb 26, 2021
Last update
Sep 8, 2021

Study contacts

Mathias Ströhle, Dr
principal investigator · General and Surgical Critical Care Medicine, Medical University of Innsbruck

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion